O TYM PODKAŚCIE 🔗

Częstotliwość aktualizacji:
every 36 days
Średnia długość dźwięku:
25 minutes
Wywiady gościnne
Język angielski
Zjednoczone Królestwo
30 odcinków
od 2 czerwca 2021
episodic

NAJNOWSZY ODCINEK 🔗

Phoebe Ashley-Norman talks with Hade Ramos and Jenniffer Angulo from the Pontificia Universidad Católica de Chile (Santiago, Chile) about Andes virus, and discuss the findings of their recent Lancet Microbe Article titled: "First nationwide full-genome characterisation of human-derived Andes virus …

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki The Lancet Microbe in conversation with.

POPRZEDNIE ODCINKI

In this episode, we discuss the Series on Rheumatic Heart Disease published jointly by The Lancet Microbe and The Lancet Regional Health – Americas. We cover why this Series matters to the scientific community, how neglected the disease remains, its incidence across the Americas, and how it's manag…
Phoebe Ashley-Norman talks with Luria Leslie Founou about neonatal sepsis in Cameroon and sub-Saharan Africa more broadly, in conversation around the Lancet Microbe Personal View "Neonatal sepsis in Africa: what are we missing" Read the Personal View here: https://www.thelancet.com/journals/lanmi…
In this episode, we discuss antimicrobial resistance (AMR) priorities, as outlined in the UK National Action Plan (NAP) for AMR, and how microbial genomics can contribute to meeting them in the UK and beyond. Guests Kate Baker, a researcher at the Department of Genetics, University of Cambridge (Ca…
Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.” Together,…
Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues. We also discuss Nipah…
Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in …
Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial …
Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions.  Global efforts invol…
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status.  From an ecol…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z The Lancet Group, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.